[ad_1]
FDA approves use of Eisai (OTCPK: ESALY + 1.8%) FYCOMPA (perampanel) CIII, alone or in combination with other medicinal products, for the treatment of pediatric patients with partial seizures and at least four years of age. Approval applies to tablet formulations and oral suspensions.
Previously, FYCOMPA was approved for use in patients aged at least 12 years old.
[ad_2]
Source link
